Skip to main content

Table 1 Baseline social demographics and clinical characteristics in breast cancer patients with ovarian function suppression

From: Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists

Characteristics

Total

Ovarian Ablation OA

GnRH agonist GnRHa

t or χ2 value

P Value

N

563

174

389

  

Age, years

 Median

44

46

43

  

 Range

22-63

30-57

22-63

  

 Mean (SD)

42.9 ± 7.7

45.2 ± 6.7

41.8 ± 7.8

5.374

<0.001

Duration of OFS

 Mean (SD), months

25.1 ± 25.4

30.3 ± 29.1

22.8 ± 22.1

3.009

0.003

Educational level

   

13.570

0.0002

 High school or below

268

103 (59.2%)

165 (42.4%)

 

 College or above

295

71 (40.8%)

224 (57.9%)

 

Annual income (RMB)

   

0.360

0.548

 ≤ 50,000

398

126 (72.4%)

272 (69.9%)

 

 > 50,000

165

48 (27.6%)

117 (30.1%)

 

Smoking habit

   

0.597

0.440

 Never or little

548

168 (96.6%)

380 (97.7%)

 

 Mostly

15

6 (3.4%)

9 (2.3%)

 

Alcohol drinking habit

   

1.210

0.271

 Never or little

556

170 (97.7%)

386 (99.2%)

  

 Mostly

7

4 (2.3%)

3 (0.8%)

  

Co-morbidity

   

0.060

0.807

 Diabetes/Hypertension

43

14 (8.0%)

29 (7.5%)

  

 None

520

160 (92.0%)

360 (92.5%)

  

Type of Surgery

   

5.852

0.016

 Mastectomy

433

145 (83.3%)

288 (74.0%)

 

 Breast-conserving

130

29 (16.7%)

101 (26.0%)

 

TNM staging

   

7.505

0.006

 I-III

400

110 (63.2%)

290 (74.6%)

 

 IV

163

64 (36.8%)

99 (25.4%)

 

Hormone Receptor Status

   

12.393

0.0004

 ER or PR Positive

526

153 (87.9%)

373 (95.9%)

 

 ER and PR Negative

37

21 (12.1%)

16 (4.1%)

 

HER2 Status

   

1.256

0.262

 Positive

130

35 (20.1%)

95 (24.4%)

 

 Negative

433

139 (79.9%)

294 (75.6%)

 

ET+OFS

 AI

395

115 (66.1%)

280 (72.0%)

0.009

0.924

 TAM

86

20 (11.5%)

66 (17.0%)

  

 Ful

46

19(10.9%)

27(6.9%)

  

 None

36

20 (11.5%)

16 (4.1%)

 Â